Vicore Pharma Holding AB (publ) (VCRE)
NASDAQ: VCRE · Real-Time Price · USD
12.65
-1.13 (-8.20%)
At close: Jul 13, 2026, 4:00 PM EDT
11.79
-0.86 (-6.80%)
Pre-market: Jul 14, 2026, 8:04 AM EDT
Vicore Pharma Holding AB Revenue
Vicore Pharma Holding AB had revenue of 602.00K SEK in the quarter ending March 31, 2026, a decrease of -32.51%. This brings the company's revenue in the last twelve months to 3.53M, down -41.17% year-over-year. In the year 2025, Vicore Pharma Holding AB had annual revenue of 3.82M, down -96.51%.
Revenue (ttm)
3.53M SEK
Revenue Growth
-41.17%
P/S Ratio
958.74
Revenue / Employee
88,175 SEK
Employees
40
Market Cap
355.32M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.82M | -105.53M | -96.51% |
| Dec 31, 2024 | 109.35M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vanda Pharmaceuticals | 217.78M |
| Q32 Bio | 53.74M |
| Fennec Pharmaceuticals | 51.00M |
| X4 Pharmaceuticals | 9.01M |
| Fate Therapeutics | 6.32M |
| Adlai Nortye | 5.00M |
| Lyell Immunopharma | 31.00K |
| Inhibikase Therapeutics | 1.00 |
VCRE News
- 7 days ago - Vicore Pharma to Participate in the Leerink Therapeutics Forum - Accesswire
- 5 weeks ago - Vicore Pharma Holding AB Transcript: Status update - Transcripts
- 5 weeks ago - Vicore Pharma Holding AB Press release: Status update - Filings
- 5 weeks ago - Vicore Pharma Holding AB Slides: Status update - Filings
- 5 weeks ago - Vicore Pharma Holding AB Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Vicore Pharma Holding AB Slides: Company presentation - Filings
- 2 months ago - Vicore Pharma Holding AB Quarterly report: Q1 2026 - Filings
- 3 months ago - Vicore Pharma Holding AB Slides: Company presentation - Filings